From Record Backlog to Bruising Selloff: TKMS Awaits Crucial Decisions in Ottawa and Berlin
TKMS stock falls 11.5% despite €20.6B order backlog, nearing oversold. Upcoming Canada submarine project (end of June) and…
Novo Nordisk’s Buyback Blitz and Oral Wegovy Surge Counter a Bruising Year
Novo Nordisk pushes forward with a DKK 15 billion buyback and oral Wegovy success, while high-dose injectable data…